New Treatment Option for Pancreatic Cancer

NCT01364805 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Intravenous Vitamin C
DRUG: Gemcitabine

Sponsor

Jeanne Drisko, MD, CNS, FACN

Collaborators

[object Object]
[object Object]